Latest Quarterly Snapshot

Ispire Technology (ISPR) has just posted its Q2 2026 numbers, with revenue of US$20.3 million and a basic EPS loss of US$0.12 setting the tone for the quarter. The company reported quarterly revenue of US$41.8 million in Q2 2025 and US$20.3 million in Q2 2026, while basic EPS shifted from a loss of US$0.14 to a loss of US$0.12. Trailing twelve month figures show revenue of US$97.0 million against a net loss of US$35.5 million and basic EPS of US$0.62 in losses. Margins remain under pressure, so this update focuses on how the top line compares with ongoing losses and what that implies for the path toward healthier profitability.

See our full analysis for Ispire Technology.

With the latest results on the table, the next step is to compare these numbers with the most widely held market narratives to see which views hold up and which start to look stretched.

Losses Deepen On US$96.97 Million In TTM Sales

• Over the last twelve months, Ispire generated US$96.97 million of revenue and reported a net loss of US$35.51 million, equal to a basic EPS loss of US$0.62.
• What stands out for a bearish view is the gap between 10.7% revenue growth per year and losses that have expanded at about 62.8% per year over five years, which aligns with concerns about earnings quality and scale:
  • Bears highlight that negative shareholders’ equity, alongside a net loss of US$35.51 million on under US$100 million of sales, points to a business model that has not yet covered its cost base.
  • They also point to less than one year of cash runway as a key risk when combined with multi year loss growth of roughly 62.8% per year, arguing that funding and dilution worries sit ahead of any focus on revenue growth.

Stay on top of how these growing losses and the balance sheet risks shape the cautious narrative around Ispire. 🐻 Ispire Technology Bear Case

Q2 Revenue Drop To US$20.29 Million Versus Q1

• Within 2026, revenue was US$30.35 million in Q1 and US$20.29 million in Q2, while quarterly net losses moved from US$3.26 million to US$6.60 million and basic EPS losses went from US$0.06 to US$0.12.
• Supporters looking for a more constructive angle will notice that the Q2 loss of US$6.60 million is smaller than the Q4 2025 loss of US$14.79 million, which partially tempers the bearish focus on widening losses over the longer five year period:
  • Optimistic investors may point out that, compared with the Q4 2025 basic EPS loss of US$0.26, the Q2 2026 basic EPS loss of US$0.12 suggests that, at least quarter to quarter, the earnings line is not moving in one direction only.
  • At the same time, the combination of weaker quarterly revenue than Q1 2026 and a larger quarterly loss versus that same quarter means this short term improvement versus Q4 2025 does not yet clearly support a sustained bullish profitability story.

P/S Of 1.1x Versus 2.4x Industry Average

• Ispire currently trades on a P/S of 1.1x, compared with a peer average of 1.5x and a Global Tobacco industry average of 2.4x, while the share price is US$1.85.
• For investors weighing a more constructive narrative, the discount P/S multiple against peers sits in tension with the financial risk profile, so the mixed picture is central to any bullish or cautious view:
  • Bulls may argue that a 1.1x P/S against a 2.4x industry level could signal the market is pricing in the negative equity, cash runway of under one year and high share price volatility more heavily than the 10.7% revenue growth rate.
  • Critics counter that, as long as the company remains unprofitable with a trailing twelve month net loss of US$35.51 million and negative shareholders’ equity, the lower P/S might simply reflect these balance sheet and earnings risks rather than a clear valuation opportunity.

If you want a broader context on how other companies with similar risk and reward trade, you can compare this setup with a screened list of stocks that pair financial resilience with more robust earnings profiles via the solid balance sheet and fundamentals stocks screener (44 results).

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Ispire Technology's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Given the mixed messages in the recent results and valuation, it makes sense to review the underlying data yourself and decide how much risk you are comfortable holding. Before settling on a view, take a closer look at the 4 important warning signs.

Explore Alternatives

Ispire's combination of a US$35.51 million loss on US$96.97 million in sales, negative equity and less than one year of cash runway highlights meaningful balance sheet strain.

If you want ideas with sturdier foundations, use the solid balance sheet and fundamentals stocks screener (44 results) to quickly zero in on companies where financial strength helps reduce this kind of risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.